Edward Stenehjem1,2, Adam L Hersh3, Whitney R Buckel4, Peter Jones1, Xiaoming Sheng5, R Scott Evans6,7, John P Burke1,8, Bert K Lopansri1,8, Rajendu Srivastava9,10, Tom Greene5, Andrew T Pavia3. 1. Division of Clinical Epidemiology and Infectious Diseases, Intermountain Medical Center, Murray, Utah. 2. Division of Infectious Diseases, Stanford University School of Medicine, California. 3. Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City. 4. Department of Pharmacy, Intermountain Medical Center, Murray, Utah. 5. Study Design and Biostatistics Center, University of Utah School of Medicine, Salt Lake City. 6. Medical Informatics, Intermountain Healthcare, Salt Lake City. 7. Biomedical Informatics, University of Utah, Salt Lake City. 8. Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City. 9. Institute for Healthcare Delivery Research, Intermountain Healthcare, Salt Lake City. 10. Division of Pediatric Inpatient Medicine, University of Utah School of Medicine, Salt Lake City.
Abstract
Background: Studies on the implementation of antibiotic stewardship programs (ASPs) in small hospitals are limited. Accreditation organizations now require all hospitals to have ASPs. Methods: The objective of this cluster-randomized intervention was to assess the effectiveness of implementing ASPs in Intermountain Healthcare's 15 small hospitals. Each hospital was randomized to 1 of 3 ASPs of escalating intensity. Program 1 hospitals were provided basic antibiotic stewardship education and tools, access to an infectious disease hotline, and antibiotic utilization data. Program 2 hospitals received those interventions plus advanced education, audit and feedback for select antibiotics, and locally controlled antibiotic restrictions. Program 3 hospitals received program 2 interventions plus audit and feedback on the majority of antibiotics, and an infectious diseases-trained clinician approved restricted antibiotics and reviewed microbiology results. Changes in total and broad-spectrum antibiotic use within programs (intervention versus baseline) and the difference between programs in the magnitude of change in antibiotic use (eg, program 3 vs 1) were evaluated with mixed models. Results: Program 3 hospitals showed reductions in total (rate ratio, 0.89; confidence interval, .80-.99) and broad-spectrum (0.76; .63-.91) antibiotic use when the intervention period was compared with the baseline period. Program 1 and 2 hospitals did not experience a reduction in antibiotic use. Comparison of the magnitude of effects between programs showed a similar trend favoring program 3, but this was not statistically significant. Conclusions: Only the most intensive ASP intervention was associated with reduction in total and broad-spectrum antibiotic use when compared with baseline. Clinical Trials Registration: NCT03245879.
RCT Entities:
Background: Studies on the implementation of antibiotic stewardship programs (ASPs) in small hospitals are limited. Accreditation organizations now require all hospitals to have ASPs. Methods: The objective of this cluster-randomized intervention was to assess the effectiveness of implementing ASPs in Intermountain Healthcare's 15 small hospitals. Each hospital was randomized to 1 of 3 ASPs of escalating intensity. Program 1 hospitals were provided basic antibiotic stewardship education and tools, access to an infectious disease hotline, and antibiotic utilization data. Program 2 hospitals received those interventions plus advanced education, audit and feedback for select antibiotics, and locally controlled antibiotic restrictions. Program 3 hospitals received program 2 interventions plus audit and feedback on the majority of antibiotics, and an infectious diseases-trained clinician approved restricted antibiotics and reviewed microbiology results. Changes in total and broad-spectrum antibiotic use within programs (intervention versus baseline) and the difference between programs in the magnitude of change in antibiotic use (eg, program 3 vs 1) were evaluated with mixed models. Results: Program 3 hospitals showed reductions in total (rate ratio, 0.89; confidence interval, .80-.99) and broad-spectrum (0.76; .63-.91) antibiotic use when the intervention period was compared with the baseline period. Program 1 and 2 hospitals did not experience a reduction in antibiotic use. Comparison of the magnitude of effects between programs showed a similar trend favoring program 3, but this was not statistically significant. Conclusions: Only the most intensive ASP intervention was associated with reduction in total and broad-spectrum antibiotic use when compared with baseline. Clinical Trials Registration: NCT03245879.
Authors: Tina M Khadem; Howard J Ergen; Heather J Salata; Christina Andrzejewski; Erin K McCreary; Rima C Abdel Massih; J Ryan Bariola Journal: Open Forum Infect Dis Date: 2022-05-09 Impact factor: 4.423
Authors: Kevin Hsueh; Michael J Durkin; Sena J Sayood; Chinmayi Venkatram; Jason G Newland; Hilary M Babcock; David K Warren; George Turabelidze; Virginia R McKay; Erin C Rachmiel; Kate Peacock; Tracey Habrock-Bach Journal: Infect Control Hosp Epidemiol Date: 2020-08-04 Impact factor: 3.254
Authors: Edward Stenehjem; Anthony Wallin; Katherine E Fleming-Dutra; Whitney R Buckel; Valoree Stanfield; Kimberly D Brunisholz; Jeff Sorensen; Matthew H Samore; Raj Srivastava; Lauri A Hicks; Adam L Hersh Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 20.999
Authors: Jannicke Slettli Wathne; Lars Kåre Selland Kleppe; Stig Harthug; Hege Salvesen Blix; Roy M Nilsen; Esmita Charani; Ingrid Smith Journal: Antimicrob Resist Infect Control Date: 2018-09-10 Impact factor: 4.887
Authors: Deverick J Anderson; Shera Watson; Rebekah W Moehring; Lauren Komarow; Matthew Finnemeyer; Rebekka M Arias; Jacqueline Huvane; Carol Bova Hill; Nancie Deckard; Daniel J Sexton Journal: JAMA Netw Open Date: 2019-08-02
Authors: Valerie M Vaughn; Tejal Gandhi; Anna Conlon; Vineet Chopra; Anurag N Malani; Scott A Flanders Journal: Clin Infect Dis Date: 2019-09-27 Impact factor: 9.079
Authors: Valerie M Vaughn; Lindsay A Petty; Scott A Flanders; Anurag N Malani; Twisha Patel; Steven J Bernstein; Lama M Hsaiky; Rama Thyagarajan; Danielle Osterholzer; Elizabeth McLaughlin; Jennifer K Horowitz; Tejal N Gandhi Journal: Open Forum Infect Dis Date: 2020-01-11 Impact factor: 3.835
Authors: Claire E Ciarkowski; Tristan T Timbrook; Polina V Kukhareva; Karli M Edholm; Nathan D Hatton; Christy L Hopkins; Frank Thomas; Matthew N Sanford; Elena Igumnova; Russell J Benefield; Kensaku Kawamoto; Emily S Spivak Journal: Open Forum Infect Dis Date: 2020-10-19 Impact factor: 3.835
Authors: Katherine E Goodman; Sara E Cosgrove; Lisa Pineles; Laurence S Magder; Deverick J Anderson; Elizabeth Dodds Ashley; Ronald E Polk; Hude Quan; William E Trick; Keith F Woeltje; Surbhi Leekha; Anthony D Harris Journal: Clin Infect Dis Date: 2021-07-15 Impact factor: 20.999